{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:48:07Z","timestamp":1788220087190,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["23390149 (KS)"],"award-info":[{"award-number":["23390149 (KS)"]}]},{"name":"Research Grant from the Smoking Research Foundation (KS)","award":["26460240 (TN)"],"award-info":[{"award-number":["26460240 (TN)"]}]},{"name":"Research Grant from the Smoking Research Foundation (KS)","award":["16K10195 (AM, TN)"],"award-info":[{"award-number":["16K10195 (AM, TN)"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbr.2016.09.050","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T19:54:21Z","timestamp":1477338861000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions"],"prefix":"10.1016","volume":"317","author":[{"given":"Tomoyuki","family":"Tashiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.09.050_bib0005","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.bbr.2016.09.050_bib0010","first-page":"96","article-title":"Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study","volume":"172C","author":"Fried","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2016.09.050_bib0015","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00006842-200107000-00015","article-title":"Association of depression and diabetes complications: a meta-analysis","volume":"63","author":"de Groot","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbr.2016.09.050_bib0020","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9617-0","article-title":"Indoleamine-2,3-dioxygenase\/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes","author":"da Silva Dias","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2016.09.050_bib0025","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/jir.1995.15.617","article-title":"Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes","volume":"15","author":"Hu","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0030","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00702-011-0741-3","article-title":"The role of the kynurenine metabolism in major depression","volume":"119","author":"Myint","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bbr.2016.09.050_bib0035","first-page":"431","article-title":"A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase","volume":"7","author":"Christmas","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2016.09.050_bib0040","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","article-title":"Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder","volume":"62","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2016.09.050_bib0045","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"R\u00e9us","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0050","doi-asserted-by":"publisher","first-page":"29920","DOI":"10.1038\/srep29920","article-title":"Depressive symptoms as a side effect of Interferon-alpha therapy induced by induction of indoleamine 2,3-dioxygenase 1","volume":"6","author":"Murakami","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2016.09.050_bib0055","article-title":"Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues","author":"Ohta","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.bbr.2016.09.050_bib0060","article-title":"L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences","author":"Fujigaki","year":"2016","journal-title":"Neuropharmacology"},{"issue":"Pt. 5","key":"10.1016\/j.bbr.2016.09.050_bib0065","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2016.09.050_bib0070","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.09.050_bib0075","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbr.2015.11.005","article-title":"Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice","volume":"298","author":"Mahmoud","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0080","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbr.2015.07.015","article-title":"Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats","volume":"293","author":"Fischer","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0085","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.psychres.2015.06.023","article-title":"Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis","volume":"229","author":"Andreou","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0090","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/mp.2013.11","article-title":"The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression","volume":"19","author":"Lavebratt","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.09.050_bib0095","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/abbi.1993.1567","article-title":"Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia","volume":"307","author":"Saito","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbr.2016.09.050_bib0100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jneumeth.2008.02.003","article-title":"Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57\/BL6J and BALB\/c mice","volume":"171","author":"Lalonde","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2016.09.050_bib0105","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1523\/JNEUROSCI.6458-11.2012","article-title":"MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation","volume":"32","author":"Mouri","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.09.050_bib0110","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2016.09.050_bib0115","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0047-6374(99)00104-9","article-title":"Age-related changes of gene expression in mouse kidney: fluorescence differential display\u2013PCR analyses","volume":"113","author":"Iida","year":"2000","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbr.2016.09.050_bib0120","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00213-013-3175-9","article-title":"Evaluation of cognitive behaviors in young offspring of C57BL\/6J mice after gestational nicotine exposure during different time-windows","volume":"230","author":"Alkam","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.09.050_bib0125","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.bjp.0702553","article-title":"The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites","volume":"127","author":"Maurice","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.09.050_bib0130","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","author":"Wonodi","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2016.09.050_bib0135","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.schres.2014.10.026","article-title":"Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia","volume":"160","author":"Wonodi","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0140","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.09.050_bib0145","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-6147(91)90529-2","article-title":"Animal models as simulations of depression","volume":"12","author":"Willner","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2016.09.050_bib0150","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.1523\/JNEUROSCI.0440-09.2009","article-title":"Fluoxetine (prozac) binding to serotonin transporter is modulated by chloride and conformational changes","volume":"29","author":"Tavoulari","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.09.050_bib0155","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4065\/76.5.511","article-title":"Pharmacology of antidepressants","volume":"76","author":"Richelson","year":"2001","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbr.2016.09.050_bib0160","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbr.2015.04.017","article-title":"Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency","volume":"288","author":"Xu","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0165","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/2327-6924.12129","article-title":"New findings: depression, suicide, and Toxoplasma gondii infection","volume":"26","author":"Hsu","year":"2014","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"10.1016\/j.bbr.2016.09.050_bib0170","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","article-title":"Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge","volume":"62","author":"Salazar","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbr.2016.09.050_bib0175","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.09.050_bib0180","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.09.050_bib0185","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.npp.1300188","article-title":"Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat","volume":"28","author":"Shepard","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2016.09.050_bib0190","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.euroneuro.2012.06.008","article-title":"P50 sensory gating is a trait marker of the bipolar spectrum","volume":"23","author":"Cabranes","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2016.09.050_bib0195","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1399-5618.2008.00622.x","article-title":"Contributions of spectral frequency analyses to the study of P50 ERP amplitude and suppression in bipolar disorder with or without a history of psychosis","volume":"10","author":"Carroll","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbr.2016.09.050_bib0200","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0022-3956(03)00050-5","article-title":"Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter","volume":"37","author":"Stockmeier","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2016.09.050_bib0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Owens","year":"1994","journal-title":"Clin. Chem."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816306970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816306970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:14:58Z","timestamp":1657498498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816306970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"alternative-id":["S0166432816306970"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.09.050","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}